|
| xysoom |
 Geplaatst: Do-Sep-2019 02:33:59 |
 |
|
|
Geregistreerd op: 21 Jul 2019
Berichten: 195
|
Factory supply Tamoxifen Citrate/ Nolvadex CAS 54965-24-1 Tamoxifen powder
Tamoxifen Citrate is a potent and selective inhibitor of PKC (protein kinase C).
Tamoxifen citrate is known that Tamoxifen Citrate functions in PKC εtranslocation. Studies suggest that Tamoxifen Citrate functions as an estrogen receptor antagonist in breast tissue. Nolvadex uses
Once bound to the estrogen receptor Tamoxifen Citrate will not allow any other ligand to bind to the receptor. In contrast, Tamoxifen Citrate is an agonist towards this receptor in tissues of the endometrium.
Studies indicate Tamoxifen Citrate inhibits DNA synthesis and transcription by recruiting co-repressors, which stop estrogen from interacting with genes.
When combined with PAX2, Tamoxifen Citrate can inhibit the proliferation of ERBB2. It is also a high affinity activator of the GPR30 receptor. Tamoxifen Citrate is an activator of Estrogen Receptor.
Application
Tamoxifen citrate is an anticancer drug,is given to treat breast cancer.
Tamoxifen citrate is an anticancer drug,is given to treat breast cancer.Tamoxifen citrate also has proved effective when cancer has spread to other parts of the body.
Tamoxifen citrate is most effective in stopping the kind of breast cancer that thrives on estrogen.
Tamoxifen citrateis also prescribed to reduce the risk of invasive breast cancer following surgery and radiation therapy for ductal carcinoma in situ.
Tamoxifen citrate can also be used to reduce the odds of breast cancer in women at high risk of developing the disease. |
|
|
| Terug naar boven |
 
|
|
|
Tijden zijn in GMT + 1 uur
|
|
Je mag geen nieuwe onderwerpen plaatsen in dit subforum
Je mag geen reacties plaatsen in dit subforum
Je mag je berichten niet bewerken in dit subforum
Je mag je berichten niet verwijderen in dit subforum
Je mag niet stemmen in polls in dit subforum
|
Wilt u geen reclame op dit forum en genieten van extra voordelen? Klik dan vlug hier voor meer informatie!
|
